Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Fernando Lavalle-Gonzalez"'
Autor:
Hector E. Sanchez-Ibarra, Luisa M. Reyes-Cortes, Xian-Li Jiang, Claudia M. Luna-Aguirre, Dionicio Aguirre-Trevino, Ivan A. Morales-Alvarado, Rafael B. Leon-Cachon, Fernando Lavalle-Gonzalez, Faruck Morcos, Hugo A. Barrera-Saldaña
Publikováno v:
Frontiers in Pharmacology, Vol 9 (2018)
The treatment of Type 2 Diabetes Mellitus (T2DM) consists primarily of oral antidiabetic drugs (OADs) that stimulate insulin secretion, such as sulfonylureas (SUs) and reduce hepatic glucose production (e.g., biguanides), among others. The marked int
Externí odkaz:
https://doaj.org/article/e8dc387a52c344119133d7c99c2eeebd
Autor:
Jean-François Yale, Jeremy Hodson Pettus, Miguel Brito-Sanfiel, Fernando Lavalle-Gonzalez, Ana Merino-Trigo, Peter Stella, Soazig Chevalier, Raffaella Buzzetti
Publikováno v:
PLoS ONE, Vol 13, Iss 1, p e0190579 (2018)
To evaluate the effect of concomitant dipeptidyl peptidase IV inhibitor (DPPIVi) use on efficacy and safety of insulin glargine 300 U/mL (Gla-300) versus glargine 100 U/mL (Gla-100) in people with type 2 diabetes on oral antihyperglycaemic drugs.A po
Externí odkaz:
https://doaj.org/article/8a5e9a7e1ac64e8eb639da9f0c475957
Autor:
Vanessa, Gonzalez-Covarrubias, Héctor, Sánchez-Ibarra, Karla, Lozano-Gonzalez, Sergio, Villicaña, Tomas, Texis, Mauricio, Rodríguez-Dorantes, Sergio, Cortés-Ramírez, Fernando, Lavalle-Gonzalez, Xavier, Soberón, Hugo, Barrera-Saldaña
Publikováno v:
Pharmacology. 106(11-12)
Genetic variants could aid in predicting antidiabetic drug response by associating them with markers of glucose control, such as glycated hemoglobin (HbA1c). However, pharmacogenetic implementation for antidiabetics is still under development, as the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6044902e1a37bedb752abcca1c147569
https://pubmed.ncbi.nlm.nih.gov/34265779
https://pubmed.ncbi.nlm.nih.gov/34265779
Autor:
Alberto de la Fuente-García, Minerva Gómez-Flores, Leonardo Mancillas-Adame, Jorge Ocampo-Candiani, Oliverio Welsh-Lozano, Jesús Zacarías Villarreal Pérez, José Gerardo González-González, Fernando Lavalle-González
Publikováno v:
Indian Dermatology Online Journal, Vol 5, Iss 2, Pp 117-121 (2014)
Background: Topical corticosteroids are used as first line of therapy for vitiligo, although side effects such as adrenal insufficiency are possible. Objectives: To establish the role of ACTH test before, during, and after treatment with high potency
Externí odkaz:
https://doaj.org/article/a5c28c4cfe5e47d1b0d5c8db42123740
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.